연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
1807. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis.
Min BH, Hwang J, Kim NK, Park G, Kang SY, Ahn S, Ahn S, Ha SY, Lee YK, Kushima R, Van Vrancken M, Kim MJ, Park C, Park HY, Chae J, Jang SS, Kim SJ, Kim YH, Kim JI, Kim KM
J Pathol. 2016 Nov;240(3):304-314. doi: 10.1002/path.4777.
Link
1806. Estimation of Prognostic Marker Genes by Public Microarray Data in Patients with Ovarian Serous Cystadenocarcinoma.
Yang SD, Jang SS, Han JA, Park HS, Kim JI
Yonsei Med J. 2016 Jul;57(4):872-8. doi: 10.3349/ymj.2016.57.4.872.
Link
1805. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
Cha S, Lee J, Shin JY, Kim JY, Sim SH, Keam B, Kim TM, Kim DW, Heo DS, Lee SH, Kim JI
BMC Cancer. 2016 Feb 29;16:170. doi: 10.1186/s12885-016-2209-1.
Link
1804. Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome.
Suh KJ, Cheong JW, Kim Ih, Kim HJ, Shin DY1, Koh Y, Yoon SS, Min YH, Ahn JS, Kim YK, Lee YG, Lee JO, Bang SM, Mun YC, Seong CM, Park Y, Kim BS, Hong J, Park J, Lee JH, Kim S, Lee HG.
PLoS One. 2016 Nov 8;11(11):e0166245. doi: 10.1371/journal.pone.0166245. eCollection 2016.
Link
1803. The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.
Byun JM, Kim HL, Shin DY, Koh Y, Yoon SS, Seong MW, Park SS4, Kim JH5, Lee YG6, Kim Ih.
PLoS One. 2016 Oct 26;11(10):e0163998. doi: 10.1371/journal.pone.0163998. eCollection 2016.
Link
1802. Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.
Kwon JH, Koh YI, Yoon SS, Park S, Kim Ih.
Int J Hematol. 2016 Nov;104(5):574-581. Epub 2016 Jul 18.
Link
1801. Targeting Phosphatidylinositol 4-Kinase IIIα for Radiosensitization: A Potential Model of Drug Repositioning Using an Anti-Hepatitis C Viral Agent.
Kwon J, Kim DH, Park JM, Park YH, Hwang YH, Wu HG, Shin KH, Kim IA.
Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):867-876. doi: 10.1016/j.ijrobp.2016.08.007. Epub 2016 Aug 20.
Link
1800. Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells.
Yu T, Cho BJ, Choi EJ, Park JM, Kim DH, Kim IA
Oncotarget. 2016 Oct 12. doi: 10.18632/oncotarget.12597. [Epub ahead of print]
Link
1799. Inhibition of STAT3 enhances the radiosensitizing effect of temozolomide in glioblastoma cells in vitro and in vivo.
Han TJ, Cho BJ, Choi EJ, Kim DH, Song SH, Paek SH, Kim IA.
J Neurooncol. 2016 Oct;130(1):89-98. Epub 2016 Aug 10.
Link
1798. MicroRNA-203 Modulates the Radiation Sensitivity of Human Malignant Glioma Cells.
Chang JH, Hwang YH, Lee DJ, Kim DH, Park JM, Wu HG, Kim IA.
Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):412-20. doi: 10.1016/j.ijrobp.2015.10.001. Epub 2015 Oct 9.
Link